175 related articles for article (PubMed ID: 17035326)
1. Increased frequency of circulating CCR5+ CD4+ T cells in human immunodeficiency virus type 2 infection.
Soares R; Foxall R; Albuquerque A; Cortesão C; Garcia M; Victorino RM; Sousa AE
J Virol; 2006 Dec; 80(24):12425-9. PubMed ID: 17035326
[TBL] [Abstract][Full Text] [Related]
2. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
3. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.
Monceaux V; Viollet L; Petit F; Cumont MC; Kaufmann GR; Aubertin AM; Hurtrel B; Silvestri G; Estaquier J
J Virol; 2007 Dec; 81(24):13865-75. PubMed ID: 17898067
[TBL] [Abstract][Full Text] [Related]
4. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.
Karlsson I; Grivel JC; Chen SS; Karlsson A; Albert J; Fenyö EM; Margolis LB
J Virol; 2005 Sep; 79(17):11151-60. PubMed ID: 16103166
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
6. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
7. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
[TBL] [Abstract][Full Text] [Related]
8. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
[TBL] [Abstract][Full Text] [Related]
9. Increased susceptibility to HIV-1 of peripheral blood lymphocytes in acute infection with Epstein-Barr virus.
Moriuchi M; Moriuchi H
J Med Virol; 2003 Nov; 71(3):343-6. PubMed ID: 12966538
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo.
Weissman D; Dybul M; Daucher MB; Davey RT; Walker RE; Kovacs JA
J Infect Dis; 2000 Mar; 181(3):933-8. PubMed ID: 10720515
[TBL] [Abstract][Full Text] [Related]
11. Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
Zaunders JJ; Kaufmann GR; Cunningham PH; Smith D; Grey P; Suzuki K; Carr A; Goh LE; Cooper DA
J Infect Dis; 2001 Mar; 183(5):736-43. PubMed ID: 11181150
[TBL] [Abstract][Full Text] [Related]
12. Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection.
Gautier D; Beq S; Cortesão CS; Sousa AE; Cheynier R
J Virol; 2007 Nov; 81(22):12685-8. PubMed ID: 17804512
[TBL] [Abstract][Full Text] [Related]
13. Control of HIV-1 RNA load after HAART interruption: relationship with CCR5 co-receptor density and proviral DNA load in HIV-infected patients.
Soriano-Sarabia N; Vallejo A; Fernández G; Genebat M; Gutiérrez S; Muñoz-Fernández MA; Leal M
J Clin Virol; 2007 Sep; 40(1):64-7. PubMed ID: 17662650
[TBL] [Abstract][Full Text] [Related]
14. Increased frequency of CD25dimCD4+ T-cells in HIV-2 infection, a naturally occurring attenuated form of HIV-1.
Foxall RB; Soares RS; Albuquerque AS; Cortesão CS; Victorino RM; Sousa AE
Clin Immunol; 2008 May; 127(2):158-67. PubMed ID: 18313362
[TBL] [Abstract][Full Text] [Related]
15. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
[TBL] [Abstract][Full Text] [Related]
17. Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
Guan Y; Abdelwahab S; Kamin-Lewis R; DeVico AL; Lewis GK
PLoS One; 2008; 3(10):e3481. PubMed ID: 18941536
[TBL] [Abstract][Full Text] [Related]
18. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.
Binninger-Schinzel D; Müller D; Wolf T; Krause B; Meye B; Winskowsky G; Raupp S; Norley S; Brodt R; Werner A
J Med Virol; 2008 Feb; 80(2):192-200. PubMed ID: 18098144
[TBL] [Abstract][Full Text] [Related]
20. Common promoter deletion is associated with 3.9-fold differential transcription of ovine CCR5 and reduced proviral level of ovine progressive pneumonia virus.
White SN; Mousel MR; Reynolds JO; Lewis GS; Herrmann-Hoesing LM
Anim Genet; 2009 Oct; 40(5):583-9. PubMed ID: 19397512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
